UCSF

ZINC03807172

Substance Information

In ZINC since Heavy atoms Benign functionality
November 7th, 2005 35 Yes

Other Names:

(2R,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methy

(2R,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid

(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid

(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid

(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid

(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-pi

(2R,4R)-1-[5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid

(2R,4R)-4-Methyl-1-((S)-N(sup 2)-(((RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl)sulfonyl)arginyl)pipecolic acid

(2r,4r)-4-methyl-1-[n2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-l-arginyl]-2-piperidinecarboxylic acid

(2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl)]-2-piperadinecarboxylic acid

(2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperadinecarboxylic acid; 74863-84-6; Argatroban; C04931

1-[ -5- -2-[[ -3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylicacid

troban

121785-71-5

141396-28-3; Argatroban (USAN); Argatroban hydrate (JP16); D00181; Novastan (TN)

1dwc

2-Piperidinecarboxylic acid, 1-((2S)-5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2R,4R)-

2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-

2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2R-(1(S*(R*)),2alpha,4beta))-

2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2R-(1(S*(R*)),2alpha,4beta))-; 21R-Argatroban; Argatroban; LS-114640

21R-Argatroban

4,4-Dichloro-2,2-bipyridine

4-methyl-1-(N(2)-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl)-2-piperidinecarboxylic acid

74863-84-6

82784-65-4

AC-15185

AC1L3OPA

AC1L49F4

AC1L99H9

AC1L9HII

AC1Q5QXC

Acova

AR-1A3021

Argatra

Argatroban (anhydrous)

Argatroban (BAN

Argatroban anhydrous

Argatroban monohydrate

Argatroban [INN:JAN]

Argatrobanum

Argatrobanum [Latin]

Argipidine

BIDD:GT0748

C04931

C23H36N6O5S

CHEBI:194249

CHEBI:288815

CHEMBL1166

CHEMBL59461

CID152951

CID440542

CID445156

CID92722

CPD000466348

DAP000758

DB00278

DK-7419

DK-7419; GN-1600; Gn1600; MCI-9038; MD-805

Exembol

FDA

GN-1600

GN1600

HMS2051N07

HMS2090L12

INN

JAN

KST-1A8419

LS-114621

LS-114640

MCI 9038

MCI-9038

MD 805

MD-805

MD805

MDI-805

MFCD00866789

MFCD00895735

MFCD23102419

MITSUBISHI INHIBITOR

MLS000759461

MLS001424093

MMTQAP

MolPort-003-987-205

MPQA

MQI-ARG-MCP

N/A

NA

NCGC00164592-01

NCGC00166413-01

Novastan

OM-805

QA-9149

SAM001246661

Slonnon

SMR000466348

TL8005144

UNII-OCY3U280Y3

USAN)

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -0.78 6.76 -106.51 7 11 0 182 508.645 10

Vendor Notes

Note Type Comments Provided By
PUBCHEM_PATENT_ID EP0489070B1; EP0530167A1; EP0540747A1; EP0560913A1; EP0565897A1; EP0608828A1; EP0608828B1; EP0608831A1; EP0608831B1; EP0621036A1; EP0621036B1; EP0627929A1; EP0627929B1; EP0656008A1; EP0656008B1; EP0664786B1; EP0665009A1; EP0665009B1; EP0669131A1; EP066913 IBM Patent Data
Target Others Selleck Chemicals
Target Thrombin Selleck Chemicals

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
THRB-1-E Prothrombin (cluster #1 Of 8), Eukaryotic Eukaryotes 1 0.36 Binding ≤ 10μM
TRY1-3-E Trypsin I (cluster #3 Of 5), Eukaryotic Eukaryotes 5000 0.21 Binding ≤ 10μM
THRB-1-E Thrombin (cluster #1 Of 1), Eukaryotic Eukaryotes 38 0.30 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
THRB_RAT P18292 Thrombin, Rat 1 0.36 Binding ≤ 1μM
THRB_BOVIN P00735 Thrombin, Bovin 61 0.29 Binding ≤ 1μM
THRB_HUMAN P00734 Thrombin, Human 1 0.36 Binding ≤ 1μM
THRB_BOVIN P00735 Thrombin, Bovin 61 0.29 Binding ≤ 10μM
THRB_HUMAN P00734 Thrombin, Human 1 0.36 Binding ≤ 10μM
THRB_RAT P18292 Thrombin, Rat 1 0.36 Binding ≤ 10μM
TRY1_BOVIN P00760 Trypsin I, Bovin 2900 0.22 Binding ≤ 10μM
THRB_HUMAN P00734 Thrombin, Human 38 0.30 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Cell surface interactions at the vascular wall
Common Pathway
G alpha (q) signalling events
Gamma-carboxylation of protein precursors
Intrinsic Pathway
Peptide ligand-binding receptors
Platelet Aggregation (Plug Formation)
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l
Removal of aminoterminal propeptides from gamma-carboxylated proteins
Thrombin signalling through proteinase activated receptors (PARs)
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulu

Analogs ( Draw Identity 99% 90% 80% 70% )